Design Therapeutics
Latest round
- Series B
Last raised
- Jan 2021
Total raised
- $171M
Investors
- 13
About Design Therapeutics
Design Therapeutics Inc. is a US-based biopharmaceutical company focused on developing small molecule therapies to treat serious genetic diseases, leveraging its proprietary GeneTAC platform to create targeted treatment options. Design Therapeutics Inc. specializes in developing solutions for monogenic repeat expansion disorders. Founded by Pratik Shah, the company is headquartered in Carlsbad, US.00 mn. Design Therapeutics focuses on creating innovative small molecule therapeutic candidates targeting genetic diseases without effective treatments. Their GeneTAC (Gene Targeted Chimera) platform addresses conditions such as Friedreich ataxia and Huntington’s disease. Their products primarily target patients with these disorders and are marketed mainly in the United States, with potential for future expansion. Revenue generation is facilitated through partnerships and collaborations with healthcare providers, research institutions, and pharmaceutical companies, focusing on licensing agreements and collaborative research.
Who invested in Design Therapeutics
13 investors across 2 rounds
See all investors in Design Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Design Therapeutics
Who invested in Design Therapeutics?
Design Therapeutics has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Design Therapeutics raised?
Design Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Design Therapeutics last raise money?
Design Therapeutics's most recent round on record is a Series B, in Jan 2021.
What does Design Therapeutics do?
Design Therapeutics is a biotechnology company.
Where is Design Therapeutics headquartered?
Design Therapeutics is headquartered in Carlsbad, US.
Which VCs invest in companies like Design Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Design Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Design Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.